Assignment history

Inventors

The sole named inventor is Mohammed N. Islam. At the time of the application filing and the assignment of interest, Mohammed N. Islam was the founder and Chief Technology Officer of Omni Medsci Inc., and also a tenured Professor of Optics and Photonics, and Biomedical Engineering, at the University of Michigan's College of Engineering.

Original assignee

Name: Omni Medsci Inc.
Product embodying the claims: Omni Medsci Inc. does not appear to ship products embodying the claims of US122684475. Instead, the company is primarily involved in patent assertion.
Primary line of business: Patent assertion and licensing, focused on optical technology related to medical devices, as developed by Mohammed N. Islam.
Current status: Operating, with ongoing patent litigation as of early 2025.

Assignment timeline

• 2024-10-25 (executed) / recorded 2025-02-20 — Reel 006423/0488
  • Conveyance: Assignment of Assignors Interest
  • Assignor: ISLAM, MOHAMMED N.
  • Assignee: OMNI MEDSCI, INC.
  • Correspondent: LAW OFFICE OF LING ZHANG, 1999 S BASCOM AVE STE 700, CAMPBELL, CA 95008. This correspondent recurs in other patents by entities associated with Mohammed N. Islam.
  • Context: Transfer of inventor's interest to the company (original assignee).

Timeline diagram

timeline
    title Ownership of US 12268475
    2024 : Application filed
    2024 : Inventor assigned to Omni Medsci Inc
    2025 : Issued

NPE / troll-pattern signals

1. Shell-entity transfer — Not present. The only recorded assignment is from the inventor, Mohammed N. Islam, to Omni Medsci Inc. (Reel 006423/0488). This is a standard initial assignment, not a transfer from an operating company to a shell entity.
2. Known asserter in the chain — Present. Omni Medsci Inc. is identified as a patent asserter. It has filed infringement complaints against companies like Fossil, OnePlus, Oura Health, and Samsung, concerning wearable devices that measure physiological parameters.
3. Repeat correspondent across the chain — Unclear. There is only one assignment in this patent's chain, from the inventor to Omni Medsci Inc. The correspondent, LAW OFFICE OF LING ZHANG (Reel 006423/0488), is noted as recurring in other patent chains associated with Mohammed N. Islam and related entities. However, without multiple assignments within this specific chain, this signal cannot be definitively marked as "present" based on the "across the chain" criterion.
4. Cascading transfers — Not present. There is only one assignment recorded for this patent.
5. Pre-litigation transfer — Not present. The assignment from the inventor to Omni Medsci Inc. occurred on 2024-10-25, before the patent was granted on 2025-04-08. Any litigation specifically naming US12268475 would occur after its issuance. The related litigation mentioned for Omni Medsci Inc. involving other patents in 2024 does not involve this patent's pre-grant assignment.
6. Bankruptcy fire-sale — Not present. There is no indication of bankruptcy for Omni Medsci Inc.
7. Privateering — Unclear. While Omni Medsci Inc. is an active patent asserter, there is no explicit evidence in the provided information to suggest that the patent was transferred to Omni Medsci Inc. by an operating company for the purpose of asserting it on their behalf against competitors. The transfer was directly from the inventor.
8. Defensive aggregator (anti-NPE) — Not present. The patent is currently held by Omni Medsci Inc., an asserting entity.

Verdict

NPE — high confidence

Justification: The current assignee, Omni Medsci Inc. (Reel 006423/0488, recorded 2025-02-20), is a known patent assertion entity that actively files infringement lawsuits against technology companies regarding wearable devices and other related technologies. This demonstrates a clear pattern of patent monetization through litigation rather than product commercialization, satisfying the "Known asserter in the chain" signal.

USPTO Assignment Center search page: https://assignmentcenter.uspto.gov/patent/index.html (search for patent number 12268475).